ProMIS Neurosciences, Inc.

NASDAQ:PMN

Biotechnology

Healthcare
$11.08 -0.14%

-$0.02 today

Market cap
$99.36M
Beta
-0.22
P/E (TTM)
-0.6
EPS (TTM)
-$4.62
52W Low $6.27High $27.40

Volume 0.13M

Average 0.07M

PMN Operating Margin

Operating income as a percentage of revenue, showing the profitability of core operations.

ProMIS Neurosciences, Inc.NASDAQ: PMN

Operating Margin · Q2 FY2026 · quarter ended Jun 2026

Operating margin not reported for Q2 FY2026

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
—— QoQ
Last fiscal yearDec 2025
—— YoY
LTMJun 2026
—— YoY
Operating Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3 years———
5 years——
10 years——

Operating Margin history

Percent of revenue · from the income statement

Latest · FY2021
-63350.5%
Year-over-year change
—

Operating Margin vs competitors

How PMN compares with its peers on the latest reported figures

PMN Competitors Peer median
Operating Margin for PMN and competitors
Company Period LTM level YoY 3-year change
ANLAdlai Nortye Ltd.LTM Jun 2024-996.4% ——
PMNProMIS Neurosciences, Inc.FY2025— ——
MPLTMapLight Therapeutics, Inc.FY2025— ——
EDSAEdesa Biotech, Inc.FY2025— ——
Peer median (excluding PMN) -996.4%——

Competitors are the stored peer set for PMN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

Mixed currencies
Metric
FY2021
Dec 2021 · CAD
FY2022
Dec 2022 · CAD
FY2023
Dec 2023 · USD
FY2024
Dec 2024 · USD
FY2025
Dec 2025 · USD
Revenue16.68K0000
Cost of Revenue5.85M010.44M00
Gross Profit(5.84M)0(10.44M)00
Gross Margin-35031.9%————
Research & Development4.95M16.09B7.88M10.64M33.38M
Selling, General & Admin3.31M7.29B6.38M6.19M6.79M
Operating Expenses4.63M23.38B8.45M16.83M40.17M
Depreciation & Amortization45.83K028.04K00
EBITDA(9.33M)(17.78B)(17.81M)2.86M(39.72M)
EBITDA Margin-55923.2%————
Operating Income(10.57M)(23.38B)(18.9M)(16.83M)(40.17M)
Operating Margin-63350.5%————
Interest Income4.73K0000
Interest Expense416.29K282.06M201.39K76.78K0
Other Income / Expenses(1.91M)5.32B1.39M19.61M448.16K
Income Before Tax(12.48M)(18.06B)(17.51M)2.78M(39.72M)
Pre-Tax Margin-74804.2%————
Income Tax Expense00000
Net Income(11.98M)(18.06B)(17.51M)2.78M(39.72M)
Net Margin-71819.3%————
EPS (Basic)(51.77)(60.25)(35.50)2.75(22.61)
EPS (Diluted)(51.77)(60.25)(35.50)2.75(22.61)
Weighted Avg Shares231.42K300.1K491.71K1.04M1.76M
Weighted Avg Shares (Diluted)231.43K300.1K491.71K1.06M1.76M

ProMIS Neurosciences, Inc.

NASDAQ:PMN

Intrinsic Alpha fair value

Locked

Current Price

$11.08

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.